Cited by 275Tuberculosis Research and EpidemiologyImmune responses and vaccinationsInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

Open access

Teitelbaum, Rachel, Glatman-Freedman, Aharona, Chen, Bing, Robbins, John B., Unanue, Emil, Casadevall, Arturo, Bloom, Barry R.·1998·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.95.26.15688PMC PMC28105

Open this paper in CoChat — free account

Abstract

Murine mAbs reactive with the surface of Mycobacterium tuberculosis were assayed for their ability to affect the course of infection in mice challenged with virulent organisms. An IgG3 mAb (9d8) specific for arabinomannan and reactive with purified antigen from a clinical isolate of M. tuberculosis conferred partial protection on mice after respiratory challenge (30–60% survival >75 days; P ≤ 0.05). Control mice pretreated with an irrelevant mAb of the same isotype succumbed to tuberculosis within 30 days. Mice with gene disruptions in interferon γ and major histocompatibility complex Class II also were partially protected from challenge. The protective mAb was neither bactericidal nor inhibitory of infection or bacterial replication. Nevertheless, it profoundly altered the nature of the granulomas in the infected lungs. Mice treated with mAb 9d8 and challenged with M. tuberculosis localized the pathogen within granuloma centers, suggesting that the mAb conferred protection by enhancing a cellular immune response.

Integrity signals

Registry

Crossref · 10.1073/pnas.95.26.15688

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,468
Self-citation
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,987
Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice
Flynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,678
Self-citation
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
Selwyn, P. A., Hartel, D. M., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & FRIEDLAND, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,572
Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections
Cattoretti, G., Becker, M. H. G., Key, G., Duchrow, M., ter, C. S. ⁄., Galle, J., & Gerdes, J. (1992) · The Journal of Pathology · doi:10.1002/path.1711680404 · Cited by 1,447
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.
Chan, J., Xing, Y., Magliozzo, R. S., & Bloom, B. R. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1111 · Cited by 1,062
Self-citation
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
Jouanguy, E., Altare, F., Lamhamedi‐Cherradi, S., Revy, P., Emile, J., Newport, M. J., Levin, M., Blanche, S., Seboun, E., Fischer, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352604 · Cited by 892
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. H., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 793
Self-citation
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival.
Armstrong, J. A., & Hart, P. D. (1975) · The Journal of Experimental Medicine · doi:10.1084/jem.142.1.1 · Cited by 537

Show all 39 references

Research works printed but not linked: 3

A M Cooper, A D Roberts, E R Rhoades, J E Callahan, D M Getzy, I M Orme Immunology 84, 423–432 (1995).
A M Dannenberg, G A W Rook Tuberculosis: Pathogenesis, Protection and Control, ed B R Bloom (Am. Soc. Microbiol., Washington, DC), pp. 463–465 (1994).
G B Mackaness, R V Blanden, F M Collins Am Rev Respir Dis 97, 337–344 (1968).

Sorted by citations

Items 101–200 of 272

Protective and Nonprotective Human Immunoglobulin M Monoclonal Antibodies toCryptococcus neoformansGlucuronoxylomannan Manifest Different Specificities and Gene Use Profiles
Maitta, R. W., Datta, K., Chang, Q., Luo, R. X., Witover, B., Subramaniam, K. S., & Pirofski, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4810-4818.2004 · Cited by 57
Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells
Rahman, S., Rehn, A. P., Rahman, J., Andersson, J., Svensson, M., & Brighenti, S. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.12.003 · Cited by 57
TB or Not TB: That Is No Longer the Question
Modlin, R. L., & Bloom, B. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007402 · Cited by 58
Self-citation
Advances in antibody-mediated immunity againstMycobacterium tuberculosis: implications for a novel vaccine strategy
Glatman‐Freedman, A. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00172-x · Cited by 52
Self-citation
M. tuberculosis: immunology and vaccination
Rook, G. A. W., Seah, G. T., & Ustianowski, A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.17305370 · Cited by 52
Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development
Chugh, S., Bahal, R. K., Dhiman, R., & Singh, R. (2024) · npj Vaccines · doi:10.1038/s41541-024-00834-y · Cited by 51
Immunogenicity of mycobacterial vesicles in humans: Identification of a new tuberculosis antibody biomarker
Ziegenbalg, A., Prados‐Rosales, R., Jenny-Avital, E. R., Kim, R. S., Casadevall, A., & Achkar, J. M. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.03.001 · Cited by 50
Self-citation
Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis
Achkar, J. M., & Prados‐Rosales, R. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.004 · Cited by 50
A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
Kawahara, J., Irvine, E. B., & Alter, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00996 · Cited by 50
Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
Correia‐Neves, M., Sundling, C., Cooper, A. M., & Källenius, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01968 · Cited by 50
Immunology of mycobacterial infections: With special reference to Mycobacterium avium subspecies paratuberculosis
Sohal, J. S., Singh, S. K., Tyagi, P., Subhodh, S., Singh, P., Singh, A. V., Narayanasamy, K., Sheoran, N., & Sandhu, K. S. (2008) · Immunobiology · doi:10.1016/j.imbio.2007.11.002 · Cited by 51
Antibody – Fc receptor interactions in protection against intracellular pathogens
Joller, N., Weber, S. S., & Oxenius, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201041340 · Cited by 49
Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan
Glatman‐Freedman, A., Casadevall, A., Dai, Z., Jacobs, W. R., Li, A., Morris, S. L., Navoa, J. A. D., Piperdi, S., Robbins, J. B., Schneerson, R., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.3225-3231.2004 · Cited by 49
Self-citation
Vaccination of Cattle withMycobacterium bovisCulture Filtrate Proteins and Interleukin-2 for Protection against Bovine Tuberculosis
Wedlock, D. N., Vesosky, B., Skinner, M. A., de Lisle, G. W., Orme, I. M., & Buddle, B. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5809-5815.2000 · Cited by 49
Mucosal immunotherapy of tuberculosis: Is there a value in passive IgA?
Reljić, R., Williams, A., & Iványi, J. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.011 · Cited by 46
Tuberculosis subunit vaccine design: The conflict of antigenicity and immunogenicity
Sable, S. B., Kalra, M., Verma, I., & Khuller, G. K. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.10.010 · Cited by 45
Mycobacterial glycoconjugates as vaccine candidates against tuberculosis
Källenius, G., Pawlowski, A., Hamasur, B., & Svenson, S. B. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.07.007 · Cited by 44
The search for new vaccines against tuberculosis
Orme, I. M. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.1.1 · Cited by 44
The Research Progress in Immunotherapy of Tuberculosis
Mi, J., Liang, Y., Liang, J., Gong, W., Wang, S., Zhang, J., Li, Z., & Wu, X. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.763591 · Cited by 45
Receptor‐Mediated Recognition ofMycobacterium tuberculosisby Host Cells
Fenton, M. J., Riley, L. W., & Schlesinger, L. S. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch25 · Cited by 43
Mucosal delivery of antigen‐coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice
Stylianou, E., Diogo, G. R., Pepponi, I., van Dolleweerd, C. J., Arias, M. A., Locht, C., Rider, C. C., Sibley, L. S., Cutting, S. M., Loxley, A., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201343887 · Cited by 42
A re-evaluation of the role of B cells in protective immunity to Chlamydia infection
Li, L., & McSorley, S. J. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.02.004 · Cited by 42
Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents
Yasui, K. (2014) · Pediatric Rheumatology · doi:10.1186/1546-0096-12-45 · Cited by 42
Mycobacterium tuberculosispellicles express unique proteins recognized by the host humoral response
Kerns, P. W., Ackhart, D. F., Basaraba, R. J., Leid, J. G., & Shirtliff, M. E. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12142 · Cited by 42
Differences in IgG responses against infection phase related Mycobacterium tuberculosis ( Mtb ) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression
Coppola, M., Arroyo, L., van Meijgaarden, K. E., Franken, K. L. M. C., Geluk, A., Barrera, L. F., & Ottenhoff, T. H. M. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.06.001 · Cited by 41
Bovine TB and the development of new vaccines
Hope, J. C., & Villarreal‐Ramos, B. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.07.003 · Cited by 41
Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides ofMycobacterium tuberculosisin Human Models of Immunity to Tuberculosis
Sable, S. B., Kumar, R., Kalra, M., Verma, I., Khuller, G. K., Dobos, K. M., & Belisle, J. T. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3547-3558.2005 · Cited by 41
Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice
Kohama, H., Umemura, M., Okamoto, Y., Yahagi, A., Goga, H., Harakuni, T., Matsuzaki, G., & Arakawa, T. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.005 · Cited by 40
Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis
Olivares, N., Puig, A., Aguilar, D., Moya, A., Cádiz, A., Otero, O., Izquierdo, L., Falero, G., Solís, R. L., Orozco, H., et al. (2009) · Tuberculosis · doi:10.1016/j.tube.2009.02.003 · Cited by 39
Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis
Ferguson, J. S., & Schlesinger, L. S. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.2000.0242 · Cited by 38
Changes in Avidity and Level of Immunoglobulin G Antibodies to Mycobacterium tuberculosis in Sera of Patients Undergoing Treatment for Pulmonary Tuberculosis
Arias‐Bouda, L. M. P., Kuijper, S., Werf, A. V. D., Nguyen, L. N., Jansen, H. M., & Kolk, A. H. J. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.4.702-709.2003 · Cited by 38
Expression of aMycobacterium tuberculosisArabinomannan Antigen In Vitro and In Vivo
Schwebach, J. R., Casadevall, A., Schneerson, R., Dai, Z., Wang, X., Robbins, J. B., & Glatman‐Freedman, A. (2001) · Infection and Immunity · doi:10.1128/iai.69.9.5671-5678.2001 · Cited by 38
Self-citation
Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis
Encinales, L., Zúñiga, J., Granados‐Montiel, J., Yunis, M., Granados, J., Almeciga, I., Clavijo, O. P., Awad, C. E., Collazos, V., Vargas-Rojas, M. I., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.11.005 · Cited by 37
Tuberculosis vaccines and therapeutic drug: challenges and future directions
An, Y., Ni, R., Li, Z., Yang, L., Ye, Z., Li, L., Parkkila, S., Aspatwar, A., & Gong, W. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00243-6 · Cited by 38
The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation
Olivares, N., Marquina, B., Mata‐Espinosa, D., Zatarain-Barrón, Z. L., Espitia-Pinzón, C., Estrada, I., Parada, C., Collin, M., Rook, G. A. W., & Hernández‐Pando, R. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12069 · Cited by 36
An Inflammatory Story: Antibodies in Tuberculosis Comorbidities
McLean, M. R., Lu, L. L., Kent, S. J., & Chung, A. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02846 · Cited by 37
Role of B Cells and Antibodies in Acquired Immunity against Mycobacterium tuberculosisPreprint
Achkar, J. M., Chan, J., & Casadevall, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018432 · Cited by 35
Self-citation
HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
van Woudenbergh, E., Irvine, E. B., Davies, L. R. L., de Kock, M., Hanekom, W. A., Day, C. L., Fortune, S. M., & Alter, G. (2020) · mSphere · doi:10.1128/msphere.00104-20 · Cited by 37
Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis
Carpenter, S. M., & Lu, L. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.830482 · Cited by 38
The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination AgainstMycobacterium tuberculosis
Prados‐Rosales, R., Carreño, L. J., Weinrick, B. C., Batista‐González, A., Glatman-Freedman, A., Xu, J., Chan, J., Jacobs, W. R., Porcelli, S. A., & Casadevall, A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw153 · Cited by 34
Self-citation
Transmission of IgA and IgG Monoclonal Antibodies to Mucosal Fluids following Intranasal or Parenteral Delivery
Falero-Díaz, G., Challacombe, S., Rahman, D., Mistry, M., Douce, G. R., Dougan, G., Acosta, A., & Iványi, J. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024370 · Cited by 34
The effect of the administration of human gamma globulins in a model of BCG infection in mice
Olivares, N., León, A., López‐Hernández, Y., Puig, A., Cádiz, A., Falero, G., Martínez, M., Sarmiento, M. E., Fariñas, M., Infante, J. F., et al. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.006 · Cited by 33
Antibody-based vaccine strategies against intracellular pathogens
Casadevall, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.011 · Cited by 32
Self-citation
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ
Tran, A. C., Diogo, G. R., Paul, M. J., Copland, A., Hart, P. J., Mehta, N., Irvine, E. B., Mussá, T., Drake, P. M. W., Iványi, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582833 · Cited by 32
Monoclonal antibodies to lipoarabinomannan/arabinomannan – characteristics and implications for tuberculosis research and diagnostics
Corrigan, D. T., Ishida, E., Chatterjee, D., Lowary, T. L., & Achkar, J. M. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.07.001 · Cited by 33
BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components
Watanabe, Y., Watari, E., Matsunaga, I., Hiromatsu, K., Dascher, C. C., Kawashima, T., Norose, Y., Shimizu, K., Takahashi, H., Yano, I., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.04.049 · Cited by 31
Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous mice
Kalra, M., Grover, A., Mehta, N., Singh, J. K., Kaur, J., Sable, S. B., Behera, D., Sharma, P., Verma, I., & Khuller, G. K. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.007 · Cited by 30
Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection.
Kaczka, K., Mikosiński, S., Fendler, W. M., Celnik, A., & Pomorski, L. (2012) · PubMed · Cited by 30
Modulation of the Lung Inflammatory Response to Serotype 8 Pneumococcal Infection by a Human Immunoglobulin M Monoclonal Antibody to Serotype 8 Capsular Polysaccharide
Burns, T., Abadi, M. A., & Pirofski, L. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.4530-4538.2005 · Cited by 30
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis
Irvine, E. B., Nikolov, A., Khan, M. Z., Peters, J. M., Lu, R., Sixsmith, J. D., Wallace, A., van Woudenbergh, E., Shin, S. A., Karpinski, W., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01777-9 · Cited by 28
Self-citation
Critical research concepts in tuberculosis vaccine development
Delogu, G., Manganelli, R., & Brennan, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12460 · Cited by 28
Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages.
Manivannan, S., Rao, N. V., & Ramanathan, V. D. (2012) · PubMed · Cited by 28
Monoclonal Antibody-Mediated Modulation of the Humoral Immune Response against Mucosally AppliedStreptococcus mutans
Brady, L. J., van Tilburg, M. L. J. A., Alford, C. E., & McArthur, W. P. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1796-1805.2000 · Cited by 27
Integrating knowledge ofMycobacterium tuberculosispathogenesis for the design of better vaccines
Mascart, F., & Locht, C. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1102638 · Cited by 25
PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7
Rocha, J. N., Dangott, L. J., Mwangi, W., Alaniz, R. C., Bordin, A. I., Cywes‐Bentley, C., Lawhon, S. D., Pillai, S. D., Bray, J. M., Pier, G. B., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.028 · Cited by 23
Production of Antibodies against Glycolipids from the Mycobacterium tuberculosis Cell Wall in Aerosol Murine Models of Tuberculosis
Cardona, P.-J., Julián, E., Vallès, X., Gordillo, S., Muñoz, M., Luquin, M., & Ausina, V. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01088.x · Cited by 23
Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan
Liu, Y., Chen, T., Zhu, Y., Furey, A., Lowary, T. L., Chan, J., Bournazos, S., Ravetch, J. V., & Achkar, J. M. (2023) · JCI Insight · doi:10.1172/jci.insight.167960 · Cited by 22
Immunity to TB and Targets for Immunotherapy
Juarrero, M. G. (2012) · Immunotherapy · doi:10.2217/imt.11.168 · Cited by 22
Specificity and Diversity of Antibodies toMycobacterium tuberculosisArabinomannan
Navoa, J. A. D., Laal, S., Pirofski, L., McLean, G. R., Dai, Z., Robbins, J. B., Schneerson, R., Casadevall, A., & Glatman‐Freedman, A. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.1.88-94.2003 · Cited by 22
Self-citation
Antibody-Fab and -Fc features promote Mycobacterium tuberculosis restriction
Grace, P. S., Peters, J. M., Sixsmith, J. D., Lu, R., Irvine, E. B., Luedemann, C., Fenderson, B. A., Vickers, A. J., Slein, M. D., McKitrick, T. R., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.05.004 · Cited by 22
Self-citation
Mycobacterium Tuberculosis Virulence: Insights and Impact on Vaccine Development
Delogu, G., Provvedi, R., Sali, M., & Manganelli, R. (2015) · Future Microbiology · doi:10.2217/fmb.15.26 · Cited by 22
Components of Protective Immunity
Zhang, G., Zhang, Y., & Samuel, J. E. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-4315-1_5 · Cited by 21
A case for passive immunoprophylaxis against tuberculosis
Reljić, R., & Iványi, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70658-2 · Cited by 21
Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates
Ishida, E., Corrigan, D. T., Chen, T., Liu, Y., Kim, R. S., Song, L., Rutledge, T. W., Magee, D. M., LaBaer, J., Lowary, T. L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104897 · Cited by 20
“The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design” – Meeting report
Boggiano, C., Eichelberg, K., Ramachandra, L., Shea, J., Ramakrishnan, L., Behar, S. M., Ernst, J., Porcelli, S. A., Maeurer, M. J., & Kornfeld, H. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.04.007 · Cited by 21
Tuberculosis vaccine candidates based on mycobacterial cell envelope components
Sarmiento, M. E., Álvarez, N., Chin, K. L., Bigi, F., Tirado, Y., García, M. Á., Anis, F. Z., Norazmi, M. N., & Acosta, A. (2019) · Tuberculosis · doi:10.1016/j.tube.2019.01.003 · Cited by 20
TB or not to be: what specificities and impact do antibodies have during tuberculosis?
Hermann, C., & King, C. G. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab015 · Cited by 19
Vaccines to prevent tuberculosis infection rather than disease: Physiological and immunological aspects
Orme, I. M. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.10.008 · Cited by 19
Vaccination with Recombinant Mycobacterium tuberculosis PknD Attenuates Bacterial Dissemination to the Brain in Guinea Pigs
Skerry, C. M., Pokkali, S., Pinn, M. L., Be, N. A., Harper, J. S., Karakousis, P. C., & Jain, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066310 · Cited by 19
Transcriptomics: The Key to Biomarker Discovery During Tuberculosis?
van Rensburg, I. C., & Loxton, A. G. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.15.16 · Cited by 19
Biodistribution of liposome‐entrapped human gamma‐globulin
García‐Santana, M. A., Duconge-Soler, J., Sarmiento, M. E., Lanio‐Ruíz, M. E., Bécquer, M. A., Izquierdo, L., & Acosta, A. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.511 · Cited by 19
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection
Logan, E., Luabeya, A. K. K., Mulenga, H., Mrdjen, D., Ontong, C., Cunningham, A. F., Tameris, M. D., McShane, H., Scriba, T. J., Horsnell, W. G. C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01529 · Cited by 19
Humoral and cellular immune responses in sheep immunized with a 22 kilodalton exported protein of Mycobacterium avium subspecies paratuberculosis
Rigden, R. C., Jandhyala, D. M., Dupont, C., Crosbie-Caird, D., Lopez-Villalobos, N., Maeda, N., Gicquel, B., & Murray, A. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46785-0 · Cited by 18
The use of immunotherapy for the treatment of tuberculosis
Ramos‐Espinosa, O., Islas-Weinstein, L., Álvarez, M. P. P., López-Torres, M. O., & Hernández‐Pando, R. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1457439 · Cited by 18
The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
Alkarni, M., Lipman, M. C. I., & Lowe, D. M. (2023) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-023-00562-6 · Cited by 19
Do CD1-Restricted T Cells Contribute to Antibody-Mediated Immunity againstMycobacterium tuberculosis?
Lang, M. L., & Glatman‐Freedman, A. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.803-809.2006 · Cited by 18
Self-citation
Polysaccharide structural variability in mycobacteria: identification and characterization of phosphorylated mannan and arabinomannan
Maes, E., Coddeville, B., Kremer, L., & Guérardel, Y. (2007) · Glycoconjugate Journal · doi:10.1007/s10719-007-9036-1 · Cited by 18
The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic
Dass, S. A., Balakrishnan, V., Arifin, N., Lim, C. S. Y., Nordin, F., & Tye, G. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833715 · Cited by 17
Functional, biochemical and 3D studies ofMycobacterium tuberculosisprotein peptides for an effective anti-tuberculosis vaccine
Ocampo, M., Patarroyo, M. A., Vanegas, M., Alba, M. P., & Patarroyo, M. E. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.763221 · Cited by 17
A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease
Winthrop, K. L., Rivera, A., Engelmann, F., Rose, S. J., Lewis, A. D., Ku, J. H., Bermudez, L. E., & Messaoudi, I. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0256rc · Cited by 17
Mycobacterium tuberculosis Zinc Metalloprotease-1 Elicits Tuberculosis-Specific Humoral Immune Response Independent of Mycobacterial Load in Pulmonary and Extra-Pulmonary Tuberculosis Patients
Vemula, M. H., Ganji, R., Sivangala, R., Jakkala, K., Gaddam, S., Penmetsa, S., & Banerjee, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00418 · Cited by 17
B‐Cell Epitopes in the Immunodominant p34 Antigen ofMycobacterium aviumssp.paratuberculosisRecognized by Antibodies from Infected Cattle
Ostrowski, M., Mundo, S. L., Harris, N., Barletta, R. G., & López, O. J. (2003) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2003.01334.x · Cited by 17
Immunization with Single Oral Dose of Alginate‐Encapsulated BCG Elicits Effective and Long‐Lasting Mucosal Immune Responses
Hosseini, M., Dobakhti, F., Pakzad, S., & Ajdary, S. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12351 · Cited by 16
Tuberculosis and Atypical Mycobacterial Infections
Johnson, J. L., & Ellner, J. J. (2006) · Elsevier eBooks · doi:10.1016/b978-0-443-06668-9.50041-7 · Cited by 16
From pathogenesis to antigens: the key to shaping the future of TB vaccines
Yang, H., Lei, X., Chai, S., Su, G., & Du, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440935 · Cited by 16
Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan
Maitta, R. W. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.060 · Cited by 15
IgM but not IgG monoclonal anti-Nocardia brasiliensisantibodies confer protection against experimental actinomycetoma in BALB/c mice
Suarez, M. L. G., Salinas-Carmona, M. C., & Pérez-Rivera, I. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00575.x · Cited by 15
Bridging the gaps to overcome major hurdles in the development of next-generation tuberculosis vaccines
Kim, H., Choi, H.-G., & Shin, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193058 · Cited by 13
The adjuvant effect of manganese on tuberculosis subunit vaccine Bfrb-GrpE
Zhou, S., Cao, Q., Zhang, Z., Du, Y., Hou, Y., Zhang, X., Xie, Z., Zhou, Y., Zhu, B., Zhang, Y., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-01049-x · Cited by 14
Immune TB Antibody Phage Display Library as a Tool To Study B Cell Immunity in TB Infections
Hamidon, N. H., Suraiya, S., Sarmiento, M. E., Acosta, A., Norazmi, M. N., & Lim, T. S. (2017) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-017-2582-5 · Cited by 14
Emerging Themes for the Role of Antibodies in Tuberculosis
Tran, A. C., Kim, M., & Reljić, R. (2019) · Immune Network · doi:10.4110/in.2019.19.e24 · Cited by 14
Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches
Achkar, J. M., Casadevall, A., & Glatman‐Freedman, A. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.461 · Cited by 13
Self-citation
Determinants of natural immunity against tuberculosis in an endemic setting: factors operating at the level of macrophage–Mycobacterium tuberculosisinteraction
Gaikwad, A. N., & Sinha, S. K. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03585.x · Cited by 13
Mycobacterium tuberculosis-Secreted Protein Antigens: Immunogenicity in Baboons
Pehler, K., Brasky, K. M., Butler, T. M., & Attanasio, R. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1017215720949 · Cited by 13
Ready Preparation of Furanosyl n -Pentenyl Orthoesters from Corresponding Methyl Furanosides
Ramamurty, C. V. S., Ganney, P., Rao, C. S., & Fraser‐Reid, B. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo1021376 · Cited by 12
Syndrome of selective IgM deficiency with severe T cell deficiency associated with disseminated cutaneous mycobacterium avium intracellulaire infection.
Gharib, A., Louis, A. G., Agrawal, S., & Gupta, S. (2015) · Europe PMC (PubMed Central) · Cited by 12
Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings
Aerosol Vaccines for Tuberculosis Workshop Summary Group (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.060 · Cited by 12
Bovine paratuberculosis: recent advances in vaccine development
Santema, W. J., Rutten, V. P. M. G., & Koets, A. P. (2011) · Veterinary Quarterly · doi:10.1080/01652176.2011.633766 · Cited by 12
B lymphocytes in anti-mycobacterial immune responses: Pathogenesis or protection?
Dyatlov, A. V., Apt, A. S., & Linge, I. A. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.10.011 · Cited by 14
Antibodies Targeting the Cell Wall Induce Protection against Virulent Mycobacterium bovis Infection
Qu, M., Liang, Z., Chen, Y., Wang, Y., Wang, H., Liu, Z., Liu, Y., Dong, Y., Ge, X., Li, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03431-22 · Cited by 11

Authors: Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., & Bloom, B. R.
Affiliations: National Institutes of Health (US)
Howard Hughes Medical Institute and the Department of Microbiology and Immunology of the Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10064; Department of Pediatrics, Jacobi Medical Center, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and Department of Pathology, Washington University, St. Louis, MO 63110
ORCID: Chen, Bing
Unanue, Emil
Casadevall, Arturo
Bloom, Barry R.
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1998-12-22
Volume: 95
Issue: 26
Pages: 15688-15693
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.95.26.15688
PMC: PMC28105
OpenAlex: W2080781566
Cited by: 275
References: 39
Citations by year: 2026: 5 · 2025: 8 · 2024: 10 · 2023: 14 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 12 · 2018: 11 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 13 · 2012: 13
FWCI: 6.53
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Wellcome Trust
National Institutes of Health (5r01hl059842-23, 5r37ai033142-24)
National Heart, Lung, and Blood Institute (R01-HL059842)
National Institute of Allergy and Infectious Diseases (AI-07118, AI 33142, R01AI007118, R01AI033142, R37-AI033142)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: Mycobacterium tuberculosis, monoclonal antibodies, arabinomannan, surface antigens, protective immunity, granuloma formation, interferon-gamma, MHC class II, cell-mediated immunity, respiratory challenge, antibody-mediated protection
MeSH terms: Animals, Antibodies, Monoclonal, Antibody Specificity, Antigens, Bacterial, Antigens, Surface, Female, Genes, MHC Class II, Granuloma, Interferon-gamma, Lung, Mannans, Mice, Inbred BALB C, Mice, Inbred C57BL, Mycobacterium tuberculosis, Neutrophils, Tuberculosis, Virulence, Survival Rate, Mice, Knockout, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks